112 related articles for article (PubMed ID: 33462652)
21. FRAX-based intervention and assessment thresholds for osteoporosis in Iran.
Khashayar P; Keshtkar A; Ostovar A; Larijani B; Johansson H; Harvey NC; Lorentzon M; McCloskey E; Kanis JA
Osteoporos Int; 2019 Nov; 30(11):2225-2230. PubMed ID: 31372709
[TBL] [Abstract][Full Text] [Related]
22. A discussion of the intervention thresholds in osteoporosis treatment in Poland.
Marcinkowska M; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Marcinkowska WH; Ignaszak-Szczepaniak M; Wawrzyniak A; Dytfeld J; Horst-Sikorska W
Endokrynol Pol; 2011; 62(1):30-6. PubMed ID: 21365576
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a two-step population-based osteoporosis screening program using FRAX: the randomized Risk-stratified Osteoporosis Strategy Evaluation (ROSE) study.
Rubin KH; Rothmann MJ; Holmberg T; Høiberg M; Möller S; Barkmann R; Glüer CC; Hermann AP; Bech M; Gram J; Brixen K
Osteoporos Int; 2018 Mar; 29(3):567-578. PubMed ID: 29218381
[TBL] [Abstract][Full Text] [Related]
24. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
25. US Preventative Services Task Force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years.
Bansal S; Pecina JL; Merry SP; Kennel KA; Maxson J; Quigg S; Thacher TD
Osteoporos Int; 2015 Apr; 26(4):1429-33. PubMed ID: 25614141
[TBL] [Abstract][Full Text] [Related]
26. Osteoporosis treatment considerations based upon fracture history, fracture risk assessment, vertebral fracture assessment, and bone density in Canada.
Leslie WD; Lix LM; Binkley N
Arch Osteoporos; 2020 Jun; 15(1):93. PubMed ID: 32577922
[TBL] [Abstract][Full Text] [Related]
27. The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model.
Chakhtoura M; Leslie WD; McClung M; Cheung AM; Fuleihan GE
Osteoporos Int; 2017 Jan; 28(1):127-137. PubMed ID: 27650643
[TBL] [Abstract][Full Text] [Related]
28. A study of the value of trabecular bone score in fracture risk assessment of postmenopausal women.
Mirzaei A; Jahed SA; Nojomi M; Rajaei A; Zabihiyeganeh M
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):389-393. PubMed ID: 29880171
[TBL] [Abstract][Full Text] [Related]
29. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
30. Fracture Risk Assessment Tool (FRAX®) Results Calculated With and Without Bone Mineral Density Values for the Evaluation of Fracture Risk in Postmenopausal Women With Osteopenia.
Imerci A; Yalın Kılınç C; Aydogan NH; Karalezli MN; Savran A
J Clin Densitom; 2018; 21(4):464-471. PubMed ID: 28781230
[TBL] [Abstract][Full Text] [Related]
31. The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.
Badurski JE; Kanis JA; Johansson H; Dobreńko A; Nowak NA; Daniluk S; Jezienicka E
Pol Arch Med Wewn; 2011 May; 121(5):148-55. PubMed ID: 21610662
[TBL] [Abstract][Full Text] [Related]
32. Use of FRAX®-based fracture risk assessments to identify patients who will benefit from osteoporosis therapy.
Silverman SL; Komm BS; Mirkin S
Maturitas; 2014 Nov; 79(3):241-7. PubMed ID: 25124532
[TBL] [Abstract][Full Text] [Related]
33. 2018 update of French recommendations on the management of postmenopausal osteoporosis.
Briot K; Roux C; Thomas T; Blain H; Buchon D; Chapurlat R; Debiais F; Feron JM; Gauvain JB; Guggenbuhl P; Legrand E; Lehr-Drylewicz AM; Lespessailles E; Tremollieres F; Weryha G; Cortet B
Joint Bone Spine; 2018 Oct; 85(5):519-530. PubMed ID: 29654947
[TBL] [Abstract][Full Text] [Related]
34. Underestimated fracture risk in postmenopausal women-application of the hybrid intervention threshold.
Wang Y; Yu S; Hsu C; Tsai C; Cheng T
Osteoporos Int; 2020 Mar; 31(3):475-483. PubMed ID: 31696272
[TBL] [Abstract][Full Text] [Related]
35. Identification of patients with high osteoporosis risk: analysis of FRAX and phalangeal ultrasonography in a female population in North-East Italy.
Vogrig E; Della Martina M; Xodo S; Ganzitti LP; P Londero A; Fabiani G; Marchesoni D
Minerva Ginecol; 2014 Oct; 66(5):447-53. PubMed ID: 25245994
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women.
Chandran M; Ganesan G; Tan KB; Reginster JY; Hiligsmann M
Osteoporos Int; 2021 Jan; 32(1):133-144. PubMed ID: 32797250
[TBL] [Abstract][Full Text] [Related]
37. Predicting Fracture Risk in Younger Postmenopausal Women: Comparison of the Garvan and FRAX Risk Calculators in the Women's Health Initiative Study.
Crandall CJ; Larson J; LaCroix A; Cauley JA; LeBoff MS; Li W; LeBlanc ES; Edwards BJ; Manson JE; Ensrud K
J Gen Intern Med; 2019 Feb; 34(2):235-242. PubMed ID: 30334182
[TBL] [Abstract][Full Text] [Related]
38. [FRAX--model for 10-year fracture risk assessment. Support in the treatment of osteoporosis, according to preliminary Swedish guidelines].
Johansson H; Kanis JA; Ljunggren O; Ström O; Svensson O; Mellström D
Lakartidningen; 2011 Feb 16-22; 108(7):336-9. PubMed ID: 21539116
[No Abstract] [Full Text] [Related]
39. Low self-awareness of osteoporosis and fracture risk among postmenopausal women.
Langer FW; da Silveira Codevilla AA; Bringhenti R; Dal Osto LC; Campos TR; Martins TT; Barin AE; Rigo PH; Boufleuer ND; Santinon SF; Kipper K; Rodrigues J; Premaor MO
Arch Osteoporos; 2016 Dec; 11(1):27. PubMed ID: 27503622
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of densitometry and fracture risk assessment tool FRAX in making therapeutic decisions in osteoporosis--a study on female patients of university of medical sciences endocrinology outpatient clinic].
Ignaszak-Szczepaniak M; Dytfeld J; Michalak M; Gowin E; Horst-Sikorska W
Ginekol Pol; 2009 Jun; 80(6):424-31. PubMed ID: 19642598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
